{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:45Z","timestamp":1791357465314,"version":"4.3.1"},"reference-count":35,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Chronic pain may be treated by medical cannabis. Yet, there is scarce evidence to support the role of medical cannabis in the treatment of fibromyalgia. The aim of the study was to investigate the characteristics, safety, and effectiveness of medical cannabis therapy for fibromyalgia. Methods: A prospective observational study with six months follow-up period based on fibromyalgia patients who were willing to answer questionnaire in a specialized medical cannabis clinic between 2015 and 2017. Results: Among the 367 fibromyalgia patients, the mean age was 52.9 \u00b1 15.1, of whom 301 (82.0%) were women. Twenty eight patients (7.6%) stopped the treatment prior to the six months follow-up. The six months response rate was 70.8%. Pain intensity (scale 0\u201310) reduced from a median of 9.0 at baseline to 5.0 (p &lt; 0.001), and 194 patients (81.1%) achieved treatment response. In a multivariate analysis, age above 60 years (odds ratio [OR] 0.34, 95% C.I 0.16\u20130.72), concerns about cannabis treatment (OR 0.36, 95% C.I 0.16\u20130.80), spasticity (OR 2.26, 95% C.I 1.08\u20134.72), and previous use of cannabis (OR 2.46 95% C.I 1.06\u20135.74) were associated with treatment outcome. The most common adverse effects were mild and included dizziness (7.9%), dry mouth (6.7%), and gastrointestinal symptoms (5.4%). Conclusion: Medical cannabis appears to be a safe and effective alternative for the treatment of fibromyalgia symptoms. Standardization of treatment compounds and regimens are required.<\/jats:p>","DOI":"10.3390\/jcm8060807","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T03:38:01Z","timestamp":1559792281000},"page":"807","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Safety and Efficacy of Medical Cannabis in Fibromyalgia"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-9934","authenticated-orcid":false,"given":"Iftach","family":"Sagy","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Rabin Medical Center, Petach Tikva 49100, Israel"},{"name":"Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be\u2019er-Sheva 84101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4349-3442","authenticated-orcid":false,"given":"Lihi","family":"Bar-Lev Schleider","sequence":"additional","affiliation":[{"name":"Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be\u2019er-Sheva 84101, Israel"},{"name":"Research Department, Tikun Olam LTD, Tel-Aviv 6296602, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Abu-Shakra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be\u2019er-Sheva 84101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Novack","sequence":"additional","affiliation":[{"name":"Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be\u2019er-Sheva 84101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.37739","article-title":"Central pain mechanisms in the rheumatic diseases: Future directions","volume":"65","author":"Phillips","year":"2013","journal-title":"Arthritis Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00011","article-title":"A review of the evidence for overlap among unexplained clinical conditions","volume":"134","author":"Aaron","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: A population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","first-page":"898493","article-title":"Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study","volume":"2013","author":"Fitzcharles","year":"2013","journal-title":"Pain Res. Treat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","article-title":"Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer","volume":"49","author":"Schleider","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejim.2018.01.019","article-title":"Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly","volume":"49","author":"Abuhasira","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J. Pain"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth. Analg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/acr.22727","article-title":"Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials","volume":"68","author":"Fitzcharles","year":"2016","journal-title":"Arthritis Care Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Fiz, J., Dur\u00e1n, M., Capell\u00e0, D., Carbonell, J., and Farr\u00e9, M. (2011). Cannabis use in patients with fibromyalgia: Effect on symptoms relief and health-related quality of life. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018440"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"\u00dc\u00e7eyler, N., Sommer, C., Walitt, B., and H\u00e4user, W. (2013). Anticonvulsants for Fibromyalgia, The Cochrane Library.","DOI":"10.1002\/14651858.CD010782"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lunn, M., Hughes, R.A., and Wiffen, P.J. (2014). Duloxetine for Treating Painful Neuropathy, Chronic Pain or Fibromyalgia, The Cochrane Library.","DOI":"10.1002\/14651858.CD007115.pub3"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2147\/JPR.S134330","article-title":"Cannabis as a substitute for prescription drugs\u2014A cross-sectional study","volume":"10","author":"Corroon","year":"2017","journal-title":"J. Pain Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0269881117699616","article-title":"Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep","volume":"31","author":"Piper","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"ref_21","first-page":"S105","article-title":"Opioid complications and side effects","volume":"11","year":"2008","journal-title":"Pain Physician"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1200\/JCO.2013.52.5188","article-title":"Principles of opioid use in cancer pain","volume":"32","author":"Portenoy","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.2016.13677","article-title":"Opioids out, cannabis in: Negotiating the unknowns in patient care for chronic pain","volume":"316","author":"Choo","year":"2016","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/dar.12207","article-title":"Prevalence of medical marijuana use in California, 2012","volume":"34","author":"Induni","year":"2015","journal-title":"Drug Alcohol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nunberg, H., Kilmer, B., Pacula, R.L., and Burgdorf, J. (2011). An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California. J. Drug Policy Anal., 4.","DOI":"10.2202\/1941-2851.1017"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: A comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Walitt, B., Nahin, R.L., Katz, R.S., Bergman, M.J., and Wolfe, F. (2015). The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138024"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00228-013-1503-y","article-title":"The prevalence and incidence of medicinal cannabis on prescription in The Netherlands","volume":"69","author":"Hazekamp","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_29","first-page":"1166","article-title":"The Increasing Use of Cannabis Among Older Americans: A Public Health Crisis or Viable Policy Alternative?","volume":"57","author":"Kaskie","year":"2017","journal-title":"Gerontologist"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780391111","article-title":"A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia","volume":"39","author":"Goldenberg","year":"1996","journal-title":"Arthritis Rheum."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1533210107301834","article-title":"Medical cannabis patients: Patient profiles and health care utilization patterns","volume":"12","author":"Reiman","year":"2007","journal-title":"Complement. Health Pract. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1300\/J069v19n03_07","article-title":"Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members","volume":"19","author":"Harris","year":"2000","journal-title":"J. Addict. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1503\/cmaj.071178","article-title":"Adverse effects of medical cannabinoids: A systematic review","volume":"178","author":"Wang","year":"2008","journal-title":"CMAJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","article-title":"Cannabis for the management of pain: Assessment of safety study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"J. Pain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamainternmed.2017.5308","article-title":"The Achilles Heel of Medical Cannabis Research\u2014Inadequate Blinding of Placebo-Controlled Trials","volume":"178","author":"Casarett","year":"2018","journal-title":"JAMA Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/6\/807\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:56:30Z","timestamp":1760187390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/6\/807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["jcm8060807"],"URL":"https:\/\/doi.org\/10.3390\/jcm8060807","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]}}}